Literature DB >> 27441577

Controversies in Reduction Mammoplasty: Being A "Clean" Operation, Does It Mandate Antibiotic Prophylaxis?

Luiz Felipe Duarte Fernandes Vieira1, Alberto Ferraz De Melo Neto1, Marina Roggia Schio1, Jonathan Augusto Vidal De Oliveira1, Carlos Lacerda Andrade Almeida1, Alvaro Antonio Bandeira Ferraz2.   

Abstract

BACKGROUND: Considered a clean operation, breast surgery has surgical site infection (SSI) rates ranging from 4% to 18%, higher than the reference value for clean surgery (<3.4%). The aim of this study was to measure the incidence of SSI in patients undergoing reduction mammoplasty with and without antibiotic prophylaxis, comparing the results and defining the value of antibiotic prophylaxis.
METHODS: The study was randomized, double-blinded, and interventional. Two groups were formed randomly, with 75 patients in each. Group 1 received prophylactic antibiotic (cefazolin 2 g 30 min before surgery with repetition at 1 g every 3 h during surgery), and Group 2 (control) did not have antibiotic prophylaxis. Patients were followed until the 30th post-operative day for identification of SSI.
RESULTS: There were 13 cases of SSI, 3 in Group 1 (4.1%) and 10 in Group 2 (13.9%) (p = 0.039). Their secretion cultures were positive for Staphylococcus aureus. There were more cases of SSI in patients having greater resections (n = 9), but the difference was not significant (p = 0.051).
CONCLUSION: Infection was significantly more common in the group that did not receive prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27441577     DOI: 10.1089/sur.2016.072

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  3 in total

1.  Single dose versus 24 h antibiotic prophylaxis in reduction mammaplasty: study protocol for a randomized controlled trial.

Authors:  Daniela Francescato Veiga; Edgard da Silva Garcia; José Wilson Moreira-Filho; Evelyne Borges de Mattos Andrade; Yara Juliano; Joel Veiga-Filho; Lydia Masako Ferreira
Journal:  Trials       Date:  2020-07-02       Impact factor: 2.279

2.  Identifying the superior antibiotic prophylaxis strategy for breast surgery: A network meta-analysis.

Authors:  Tao Guo; Baiyang Chen; Fengying Rao; Ping Wu; Pengpeng Liu; Zhisu Liu; Zhen Li
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

3.  Surgical antibiotic prophylaxis use and infection prevalence in non-cosmetic breast surgery procedures at a tertiary hospital in Western Australia-a retrospective study.

Authors:  Ainslie Lavers; Wai Siong Yip; Bruce Sunderland; Richard Parsons; Sarah Mackenzie; Jason Seet; Petra Czarniak
Journal:  PeerJ       Date:  2018-10-23       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.